Introduction
We have tested how current alchemical free -energy methods work in a typical drug discovery setting. For a computational method to be useful in drug development it needs to be accurate, reproducible and efficient. In drug optimization it is often relevant to calculate relative binding energies instead of absolute. The method should also be able to discriminate between drugs that have an affinity difference of about 4 kJ/mol, corresponding to a difference of a factor of 5 in the binding constant. In this work we present a standardized approach to ligand binding. We tested 107 ligands binding to 10 proteins with two approaches. In particular, we wanted to test our recently suggested approach to speed up the calculations by using only a single intermediate state and spherical systems where the protein outside 20Å from a central atom of the ligand is ignored.
Methods
Systems: cyclin-dependent kinase 2 (CDK2), cyclooxygenase-2 (COX2), dihydrofolate reductase (DHFR), oestrogen receptor (ER), factor Xa (fXa), ferritin, glycogen phosphorylase (GP), human immunodeficiency virus protease (HIV-PT), neuraminidase (NA) and p38a MAP kinase (p38). Two setups of the proteins were employed. In the first (spherical), the protein-ligand complexes were solvated in a sphere of TIP3P water molecules with a radius of 20Å, centred on the coordinate centre of the ligand. Protein residues outside the sphere were kept in the simulations but were restrained to the starting coordinates and no nonbonded interactions were calculated. Free energies were calculated between two ligands using three intermediate states λ = 0.00, 0.50, 1.00. In the second setup (periodic), we employed periodic boundary conditions and the entire protein was included in the calculations. The protein-ligand complex or the free ligand was put into a truncated octahedral periodic box of TIP3P water molecules extending at least 10Å from the solute. In the perturbations 13 intermediate states were employed λ = 0.00, 0.05, 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 0.95, 1.00. Free energies were calculated using Bennett acceptance-ratio (BAR) approach. Simulations for spherical system were done with Q software suite. Periodic system calculations were performed with Amber software package. Table 1 : Quality metrics for calculated affinities for ten proteins using spherical setup and three λ values.The quality metrics are average unsigned error (AUE), the median unsigned error (MUE), the correlation coefficient (r2), Kendall's rank correlation coefficient τ 90 calculated only for the transformations for which both the predicted and experimental differences are statistical significantly different from zero at the 90% level. nt tot is the total number of transformations. A negative sign of r 2 indicates that r is negative. 
Conclusions
We have studied the performance of alchemical perturbation simulations, using the BAR approach, to estimate relative binding affinities for a large and diverse test set involving 107 ligands binding to ten different proteins (91 relative affinities in total).
• 49 of the calculated affinity differences agree with experimental data to within 4 kJ/mol with an average standard error of 0.3 kJ/mol.
• The ranking of the ligands for seven of the proteins is better than random.
• For the seven of ten targets, the correlation coefficient between the calculated and experimental affinities is poor, r 2 ≤ 0.4.
• Using the periodic setup gave improved results for 62% of cases. Alchemical free energy calculation employing the BAR approach is promising in calculation of the relative binding energies in lead optimisation. Using only a single intermediate state in the perturbations to speed up the calculations works only for a few proteins and is not a general approach.
